Table 2.
Reasons to include the patient in the system
| Argentina (n = 2491) | Brazil (n = 2620) | Chile (n = 3352) | Colombia (n = 2057) | LATAM (n = 10,520) | Spain (n = 18,272) | Turkey (n = 2035) | Total (n = 30,827) | |
|---|---|---|---|---|---|---|---|---|
| COPD | 1234 (49.5) | 1909 (72.9) | 1189 (35.5) | 1936 (94.1) | 6268 (59.6) | 7025 (38.4) | 1936 (95.1) | 15,230 (49.4) |
| Poorly controlled asthma | 682 (27.4) | 183 (7.0) | 325 (9.7) | 61 (3.0) | 1251 (11.9) | 2095 (11.5) | 35 (1.7) | 3381 (11.0) |
| Bronchiectasis | 127 (5.1) | 267 (10.2) | 155 (4.6) | 76 (3.7) | 625 (5.9) | 777 (4.3) | 33 (1.6) | 1435 (4.7) |
| Serum AAT concentration level below the limit of normality | 0 (0.0) | 34 (1.3) | 2 (0.1) | 0 (0.0) | 36 (0.3) | 321 (1.8) | 0 (0.0) | 357 (1.2) |
| Blood relatives of individuals with AATD | 2 (0.1) | 176 (6.7) | 11 (0.3) | 0 (0.0) | 189 (1.8) | 548 (3.0) | 28 (1.4) | 765 (2.5) |
| Spouses of individuals with AATD | 0 (0.0) | 8 (0.3) | 1 (0.0) | 0 (0.0) | 9 (0.1) | 21 (0.1) | 0 (0.0) | 30 (0.1) |
| Hepatopathy of unknown cause | 6 (0.2) | 79 (3.0) | 6 (0.2) | 0 (0.0) | 91 (0.9) | 200 (1.1) | 3 (0.1) | 294 (1.0) |
| Dyspnea and chronic cough in many family members | 272 (10.9) | 39 (1.5) | 93 (2.8) | 0 (0.0) | 404 (3.8) | 368 (2.0) | 7 (0.3) | 779 (2.5) |
| Decreased or lack of peak alpha-1 protein on proteinogram | 3 (0.1) | 17 (0.6) | 3 (0.1) | 1 (0.0) | 24 (0.2) | 551 (3.0) | 2 (0.1) | 577 (1.9) |
| Panniculitis or multiorgan vasculitis of unknown cause | 8 (0.3) | 14 (0.5) | 2 (0.1) | 0 (0.0) | 24 (0.2) | 16 (0.1) | 1 (0.0) | 41 (0.1) |
| SARS-CoV-2 infection | 4 (0.2) | 28 (1.1) | 190 (5.7) | 0 (0.0) | 222 (2.1) | 1262 (6.9) | 0 (0.0) | 1484 (4.8) |
| None of the above | 191 (7.7) | 85 (3.2) | 1453 (43.3) | 27 (1.3) | 1756 (16.7) | 5937 (32.5) | 8 (0.4) | 7701 (25.0) |
Data expressed as absolute (relative) frequencies. Percentages referred to the total number per country